Lubbock Hospital Performed First Histotripsy Procedure
University Medical Center has introduced non-invasive ultrasound technology to treat liver cancer patients.
Updated on Sept. 23, 2026 in Cancer
Live Poll
Do you believe non-invasive medical procedures will improve your local healthcare outcomes?
University Medical Center in Lubbock successfully performed its first histotripsy procedure on patient Juan Cruz. The treatment utilizes high-frequency ultrasound to eradicate tumor cells without the need for traditional surgery.
Why it matters
This technology offers a non-invasive alternative for treating tumors located near sensitive blood vessels, potentially reducing the patient's reliance on chemotherapy.
The FDA approved histotripsy technology in 2023 for the treatment of liver cancer. There are currently only two physicians trained to perform the procedure in Lubbock.
The players
Juan Cruz
He is the first patient in Lubbock to undergo the histotripsy procedure for liver cancer.
University Medical Center
This facility is the first and only hospital in Lubbock to offer histotripsy services to patients.
Dr. Tyler Mouw
He is one of two physicians at the facility specifically trained to perform this non-invasive ultrasound treatment.
Dr. Edwin Onkendi
He is one of two physicians at the facility specifically trained to perform this non-invasive ultrasound treatment.
The details
The procedure works by delivering focused ultrasound waves to create microscopic bubbles within a tumor, which effectively liquefy the diseased tissue while sparing healthy surrounding structures. By avoiding invasive surgery, doctors can treat complex tumor locations while minimizing risks to nearby vascular systems.
Timeline
The FDA approved histotripsy technology in 2023.
The Big Picture
The adoption of this procedure at University Medical Center follows the broader expansion pattern established by HistoSonics regulatory approvals. This marks a transition from limited access in major hubs like Austin to wider availability across the state of Texas.
Patients with liver tumors in the Lubbock area may now access a non-invasive treatment option that avoids traditional surgery and potentially lowers chemotherapy requirements. Those seeking this care should consult with their oncology team to determine if they meet clinical criteria.
The takeaway
Histotripsy represents a significant shift toward non-invasive oncology by using mechanical cell destruction rather than thermal or chemical methods. Residents should discuss with their physicians how this specific ultrasound technology might offer safer alternatives to traditional surgical interventions.
What happens next
HistoSonics is planning to pursue regulatory approval to expand the use of histotripsy technology for kidney and prostate cancers within the next year.
Further reading
Learn more about the latest innovations in Cancer treatment at our dedicated portal.
Live Poll
Do you believe non-invasive medical procedures will improve your local healthcare outcomes?
